Breast cancer suppressor candidate-1 (BCSC-1) is a melanoma tumor suppressor that down regulates MITF

Pigment Cell and Melanoma Research

Volumn 25, Issue 4, 2012, Pages 482-487

  Anghel, Silvia I ^a   Correa Rochal, Rafael ^a,b   Budinska, Eva ^c,d   Boliganl, Kayluz F ^a,e   Abraham, Shahnaz ^a   Colombetti, Sara ^c   Fontao, Lionel ^a   Mariotti, Agnese ^f   Rimoldi, Donata ^c   Ghanem, Ghanem E ^g   Fisher, David E ^h   Lévy, Frederic ^c,i   Delorenzi, Mauro ^c,j,k   Piguet, Vincent ^a,l  

^a UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^b HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^c UNIVERSITY OF LAUSANNE   (Switzerland)

^d MASARYK UNIVERSITY   (Czech Republic)

^e INSTITUTO NACIONAL DE ONCOLOGÍA Y RADIOBIOLOGÍA   (Cuba)

^f UNIVERSITY OF LAUSANNE   (Switzerland)

^g JULES BORDET INSTITUTE   (Belgium)

^h MASSACHUSETTS GENERAL HOSPITAL   (United States)

ⁱ DEBIOPHARM SA   (Switzerland)

^j LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^k Frontiers in Genetics National Center of Competence in Research   (Switzerland)

^l UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

more..

Author keywords

BCSC 1; Human; Melanoma; MITF; Potential biomarker; Proliferation; Tumor suppressor

Indexed keywords

BREAST CANCER SUPPRESSOR CANDIDATE 1; MICROPHTHALMIA ASSOCIATED TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR SOX10; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELL MIGRATION; CELL PROLIFERATION; DOWN REGULATION; IN VITRO STUDY; IN VIVO STUDY; MELANOMA; MELANOMA CELL; PROTEIN BINDING; PROTEIN EXPRESSION;

AMINO ACID SEQUENCE; ANIMALS; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MELANOMA; MICE; MICROPHTHALMIA-ASSOCIATED TRANSCRIPTION FACTOR; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; PROTEIN BINDING; SKIN NEOPLASMS; SOXE TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEINS;

EID: 84862637817     PISSN: 17551471     EISSN: 1755148X     Source Type: Journal    
DOI: 10.1111/j.1755-148X.2012.01018.x     Document Type: Article

References (19)

1. Carter, S.L., Negrini, M., Baffa, R., Gillum, D.R., Rosenberg, A.L., Schwartz, G.F., and Croce, C.M. (1994). Loss of heterozygosity at 11q22-q23 in breast cancer. Cancer Res. 54, 6270-6274.
2. Cheli, Y., Ohanna, M., Ballotti, R., and Bertolotto, C. (2010). Fifteen-year quest for microphthalmia-associated transcription factor target genes. Pigment Cell Melanoma Res. 23, 27-40.
3. Gray-Schopfer, V., Wellbrock, C., and Marais, R. (2007). Melanoma biology and new targeted therapy. Nature 445, 851-857.
4. Herbst, R.A., Gutzmer, R., Matiaske, F., Mommert, S., Casper, U., Kapp, A., and Weiss, J. (1999). Identification of two distinct deletion targets at 11q23 in cutaneous malignant melanoma. Int. J. Cancer 80, 205-209.
5. Hoek, K.S., Eichhoff, O.M., Schlegel, N.C., Dobbeling, U., Kobert, N., Schaerer, L., Hemmi, S., and Dummer, R. (2008a). In vivo switching of human melanoma cells between proliferative and invasive states. Cancer Res. 68, 650-656.
6. Hoek, K.S., Schlegel, N.C., Eichhoff, O.M. et al. (2008b). Novel MITF targets identified using a two-step DNA microarray strategy. Pigment Cell Melanoma Res. 21, 665-676.
7. Jaeger, J., Koczan, D., Thiesen, H.J., Ibrahim, S.M., Gross, G., Spang, R., and Kunz, M. (2007). Gene expression signatures for tumor progression, tumor subtype, and tumor thickness in laser-microdissected melanoma tissues. Clin. Cancer Res. 13, 806-815.
8. Jeffs, A.R., Glover, A.C., Slobbe, L.J. et al. (2009). A gene expression signature of invasive potential in metastatic melanoma cells. PLoS One 4, e8461.
9. Kaufmann, W.K., Nevis, K.R., Qu, P. et al. (2008). Defective cell cycle checkpoint functions in melanoma are associated with altered patterns of gene expression. J. Invest. Dermatol. 128, 175-187.
10. Levy, C., Khaled, M., and Fisher, D.E. (2006). MITF: master regulator of melanocyte development and melanoma oncogene. Trends Mol. Med. 12, 406-414.
11. Martin, E.S., Cesari, R., Pentimalli, F., Yoder, K., Fishel, R., Himelstein, A.L., Martin, S.E., Godwin, A.K., Negrini, M., and Croce, C.M. (2003). The BCSC-1 locus at chromosome 11q23-q24 is a candidate tumor suppressor gene. Proc. Natl Acad. Sci. U S A 100, 11517-11522.
12. Mazumder, D., Mitra, S., Singh, R.K., Dutta, S., Roy, A., Mondal, R.K., Basu, P.S., Roychoudhury, S., and Panda, C.K. (2010). Inactivation of CHEK1 and EI24 are associated with the development of invasive cervical carcinoma: clinical and prognostic implications. Int. J. Cancer 129, 1859-1871.
13. Rasio, D., Negrini, M., Manenti, G., Dragani, T.A., and Croce, C.M. (1995). Loss of heterozygosity at chromosome 11q in lung adenocarcinoma: identification of three independent regions. Cancer Res. 55, 3988-3991.
14. Riker, A.I., Enkemann, S.A., Fodstad, O. et al. (2008). The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis. BMC Med. Genomics 1, 13.
15. Rother, J., and Jones, D. (2009). Molecular markers of tumor progression in melanoma. Curr. Genomics 10, 231-239.
16. Stark, G.R., and Taylor, W.R. (2006). Control of the G2/M transition. Mol. Biotechnol. 32, 227-248.
17. Wirapati, P., Sotiriou, C., Kunkel, S. et al. (2008). Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures. Breast Cancer Res. 10, R65.
18. Xu, L., Shen, S.S., Hoshida, Y., Subramanian, A., Ross, K., Brunet, J.P., Wagner, S.N., Ramaswamy, S., Mesirov, J.P., and Hynes, R.O. (2008). Gene expression changes in an animal melanoma model correlate with aggressiveness of human melanoma metastases. Mol. Cancer Res. 6, 760-769.
19. Zhou, Y.Q., Chen, S.L., Ju, J.Y., Shen, L., Liu, Y., Zhen, S., Lv, N., He, Z.G., and Zhu, L.P. (2009b). Tumor suppressor function of BCSC-1 in nasopharyngeal carcinoma. Cancer Sci. 100, 1817-1822.